Pharmagreen Biotech Ownership
PHBI Stock | USD 0 0.0002 16.67% |
Pharmagreen |
Pharmagreen Pink Sheet Ownership Analysis
About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Pharmagreen Biotech last dividend was issued on the 2nd of July 2018. The entity had 1:200 split on the 2nd of July 2018. Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada. Pharmagreen Biotech is traded on OTC Exchange in the United States.The quote for Pharmagreen Biotech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Pharmagreen Biotech contact Peter BA at 702-803-9404 or learn more at https://www.pharmagreen.ca.Currently Active Assets on Macroaxis
Other Information on Investing in Pharmagreen Pink Sheet
Pharmagreen Biotech financial ratios help investors to determine whether Pharmagreen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmagreen with respect to the benefits of owning Pharmagreen Biotech security.